Article · Volume 17, Issue 1 · pp. 243–245
A Case Report on Dermatomyositis Highlighting Muscle Weakness and Rash
Raj Ahmad Rain1, Titli Bhattacharjee2, Prayushi Patel2, Mohit Badhai1, G Anil Kumar Reddy1
- 1Department of Pharmacy Practice, Parul Institute of Pharmacy and Research, Parul University, Vadodara, Gujarat, INDIA.
- 2Department of Pharmacy Practice, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, INDIA.
Abstract
The disorder is known as Dermatomyositis, a rare autoimmune condition characterized by inflammation of the muscles and specific types of skin rashes. The case report presents a 33-year-old woman with hypothyroidism that developed progressive muscular weakness, mobility problems and new rashes around her eyes. Her major symptoms included difficulty in walking without assistance and general body weakness. Physical examination at admission showed significant truncal weakness as well as reduced reflexes. Lab tests indicated increased TSH levels, CKMM, as well as low vitamin D3 levels; muscle biopsy confirmed dermatomyositis. This was further proved by other examinations including MRI and nerve conduction studies. Systemic glucocorticoids, methotrexate, Intravenous Immunoglobulin (IvIg) and supportive therapies were given to the patient leading to remarkable improvement in muscle power and the disappearance of lesions on her skin. This particular case stands out because it involves both hypothyroidism and dermatomyositis concurrently indicating that some overlapping autoimmune diseases might be present in this patient population. This underscores the importance of an integrated diagnostic approach involving biopsy of muscles, enzyme assays and imaging for accurate diagnosis and management of dermatomyositis. The treatment plan for refractory cases that consisted of IVIG demonstrated positive results thus implying individualized interventions are effective. Therefore, this case illustrates the significance of a multidisciplinary approach to managing dermatomyositis, especially in patients with other autoimmune diseases and underlines the need for close observation, personalized therapy schedules and supportive measures to optimize results.
Keywords: Case report; Dermatomyositis; Muscle weakness; Antinuclear antibody Immunosuppressants
The full text of this article is available as a PDF. Open the PDF.
